ArticleDiabetes care2020

Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study.

Björn Pasternak et al.PubMed ↗Publisher ↗

No numbers read from the abstract.